Coronary artery stent restenosis responds favorably to repeat interventions

N Jolly1, S G Ellis, I Franco

  • 1Department of Cardiology, The Cleveland Clinic Foundation, Ohio, USA.

Insights

Predictors for repeat intervention after in-stent restenosis treatment include current smoking and graft location. Rotational atherectomy and repeat percutaneous transluminal coronary angioplasty (PTCA) showed similar target vessel revascularization rates.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • In-stent restenosis (ISR) is a significant complication following percutaneous coronary intervention.
  • Identifying predictors of reintervention and comparing treatment strategies for ISR is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the independent predictors of target vessel revascularization (TVR) in patients treated for ISR.
  • To compare the efficacy of rotational atherectomy versus repeat percutaneous transluminal coronary angioplasty (PTCA) for managing ISR.

Main Methods:

  • Retrospective evaluation of 160 patients who underwent percutaneous intervention for ISR.
  • Clinical follow-up to assess TVR rates.
  • Statistical analysis to identify independent predictors and compare treatment outcomes.

Main Results:

  • Current smoking and saphenous vein graft location were identified as independent predictors of TVR.
  • No significant difference in TVR rates was observed between rotational atherectomy and repeat PTCA.
  • Both treatment modalities demonstrated comparable effectiveness in managing ISR.

Conclusions:

  • Smoking cessation and careful consideration of graft location are important for patients with ISR.
  • Rotational atherectomy and repeat PTCA are both viable options for treating ISR, with similar reintervention rates.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...